The Trump administration is reportedly preparing a significant munitions sale to Israel, valued at approximately $2.8 billion, centered around the delivery of 40,000 heavy bomb bodies. This proposed transaction, first reported by Reuters, could eventually translate into substantial orders for U.S. defense manufacturers, although no specific contractor has been named and revenue figures for individual companies remain unconfirmed.
According to a U.S. official who spoke on condition of anonymity, the package includes 20,000 MK 84 bomb bodies and 20,000 BLU-117 bomb bodies, both in the 2,000-pound class. The State Department and Israel's embassy in Washington have not yet responded to requests for comment, leaving many details of the deal under wraps.
Stage of the Proposal
The proposal has been communicated informally to the congressional committees that oversee large arms transfers, a crucial early step in the approval process. However, this does not constitute a formal Foreign Military Sale (FMS) notice, a signed agreement, or a production award. Quantities, support content, timing, and suppliers are all subject to change before any funds reach a contractor's coffers.
Potential Beneficiaries
Investors are likely to scrutinize defense stocks, particularly General Dynamics (NYSE: GD) and Boeing (NYSE: BA), given their historical involvement in similar programs. A closely related case in February 2025 provides a relevant precedent. The Defense Security Cooperation Agency (DSCA) notified Congress of a possible $2.04 billion sale covering up to 35,529 MK 84 or BLU-117 bomb bodies, 4,000 penetrator warheads, and support. That formal notice named General Dynamics, Ellwood National Forge, and the government-operated McAlester Army Ammunition Plant as prime contractors.
General Dynamics' Ordnance and Tactical Systems unit manufactures the MK 80 series bomb bodies, including the MK 84 and BLU-117, making it a plausible participant in the new sale. However, this does not confirm selection, revenue share, or order timing.
Boeing's potential involvement is more speculative. Its JDAM guidance kit can be paired with MK 84 and BLU-117 warheads, but the reported package focuses on bomb bodies and does not mention JDAM kits or Boeing specifically. Treating the full $2.8 billion as Boeing exposure would lack substantiation.
Market Reaction
On Tuesday, General Dynamics shares closed at $358.60, up about 0.5%, while Boeing finished at $209.69, down about 0.3%, according to delayed market data. These small, opposite moves do not indicate that investors have assigned the sale to either company.
Outlook
The most compelling bullish case for General Dynamics rests on the 2025 precedent and its established manufacturing capability for nearly identical bomb-body families. Conversely, the earlier program split work among three producers, allowed procurement from U.S. stockpiles, and warned that final value could be lower than the headline estimate. A larger proposed package does not guarantee a dollar-for-dollar revenue boost for any single contractor.
The next investable catalyst will be a formal U.S. notification or company disclosure naming suppliers, quantities, and delivery timelines. Until then, the $2.8 billion figure represents the proposed sale value to monitor, not a contractor backlog figure.
